<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24918057</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2211-5463</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>FEBS open bio</Title><ISOAbbreviation>FEBS Open Bio</ISOAbbreviation></Journal><ArticleTitle>Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling.</ArticleTitle><Pagination><StartPage>426</StartPage><EndPage>431</EndPage><MedlinePgn>426-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fob.2014.04.005</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is one of the main etiological agents for Hand, Foot and Mouth Disease (HFMD) and has been shown to be associated with severe clinical manifestation. Currently, there is no antiviral therapeutic for the treatment of HFMD patients owing to a lack of understanding of EV71 pathogenesis. This study seeks to elucidate the transcriptomic changes that result from EV71 infection. Human whole genome microarray was employed to monitor changes in genomic profiles between infected and uninfected cells. The results reveal altered expression of human genes involved in critical pathways including the immune response and the stress response. Together, data from this study provide valuable insights into the host-pathogen interaction between human colorectal cells and EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lui</LastName><ForeName>Yan Long Edmund</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Queensland, Australia ; Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia ; School of Chemical and Life Sciences, Singapore Polytechnic, Singapore ; Centre for Biomedical and Life Sciences, Singapore Polytechnic, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Tuan Lin</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>School of Chemical and Life Sciences, Singapore Polytechnic, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timms</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Queensland, Australia ; Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia ; Faculty of Science, Health, Education &amp; Engineering, University of the Sunshine Coast, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafner</LastName><ForeName>Louise Marie</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Queensland, Australia ; Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kian Hwa</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>School of Chemical and Life Sciences, Singapore Polytechnic, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng Lee</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Centre for Biomedical and Life Sciences, Singapore Polytechnic, Singapore ; Department of Paediatrics, University Children's Medical Institute, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEBS Open Bio</MedlineTA><NlmUniqueID>101580716</NlmUniqueID><ISSNLinking>2211-5463</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal cells</Keyword><Keyword MajorTopicYN="N">EV71, Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">HFMD, Hand, Foot and Mouth Disease</Keyword><Keyword MajorTopicYN="N">Hand, Foot and Mouth Disease</Keyword><Keyword MajorTopicYN="N">ISG, interferon stimulated genes</Keyword><Keyword MajorTopicYN="N">MOI, multiplicity of infection</Keyword><Keyword MajorTopicYN="N">Microarray</Keyword><Keyword MajorTopicYN="N">RD, rhabdomyosarcoma</Keyword><Keyword MajorTopicYN="N">Transcriptomics</Keyword><Keyword MajorTopicYN="N">mRNA profiling</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24918057</ArticleId><ArticleId IdType="pmc">PMC4050184</ArticleId><ArticleId IdType="doi">10.1016/j.fob.2014.04.005</ArticleId><ArticleId IdType="pii">S2211-5463(14)00041-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lui Y.L.E., Lin Z., Lee J.J., Chow V.T.K., Poh C.L., Tan E.L. Beta-actin variant is necessary for enterovirus 71 replication. Biochem. Biophys. Res. Commun. 2013;433:607&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">23535377</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol. 2012;2:199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.S., Yip C.C., Lau S.K., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 2010;138:1071&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu S.L., Chen J.J., Chang S.Y., Yan B.S., Hong Q.S., Singh S., Kao C.L., Chen H.Y., Su K.Y., Li K.C., Cheng C.L., Cheng H.W., Lee J.Y., Lee C.N., Yang P.C. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbes. 2011;9:58&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21238947</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.I., Weng K.F., Shih S.R. Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol. 2012;7:467&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">22439724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T.C., Guo H.R., Su H.J., Yang Y.C., Chang H.L., Chen K.T. Diseases caused by enterovirus 71 infection. Pediatr. Infect. Dis. J. 2009;28:904&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.C., Tseng H.W., Wang S.M., Wang J.R., Su I.J. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J. Clin. Virol. 2000;17:23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10814935</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Oberste M.S., Alexander J.P., Jr., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999;73:9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.S., Tseng F.C., Wang J.R., Chi C.Y., Chong P., Su I.J. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl. Trop. Dis. 2012;6:e1737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429393</ArticleId><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee K.K., Lam T.T., Chan Y.F., Bible J.M., Kamarulzaman A., Tong C.Y., Takebe Y., Pybus O.G. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J. Virol. 2010;84:3339&#x2013;3350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S., Koopmans M., Uslu G., van der Avoort H. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J. Clin. Microbiol. 2009;47:2826&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738086</ArticleId><ArticleId IdType="pubmed">19625480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., Vasilenko S., Brodvarova I., Nikolova M., Gyurova S., Gacheva M., Mitov G., Ninov N., Tsylka E., Robinson I., Frolova M., Bashkirtsev V., Martiyanova L., Rodin V. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 1979;60:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Takatsy S., Kukan E., Mihaly I., Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 1982;71:217&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.Y., Lee C.Y., Kao C.L., Shao W.Y., Lee P.I., Twu S.J., Yeh C.C., Lin S.C., Shih W.Y., Wu S.I., Huang L.M. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J. Med. Virol. 2002;67:217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">11992582</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 2001;32:236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaria V., Hariharan M., Maiti S., Pillai B., Brahmachari S.K. Host&#x2013;virus interaction: a new role for microRNAs. Retrovirology. 2006;3:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1626483</ArticleId><ArticleId IdType="pubmed">17032463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh Z., Mallick B., Chakrabarti J. Cellular versus viral microRNAs in host&#x2013;virus interaction. Nucleic Acids Res. 2009;37:1035&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2651794</ArticleId><ArticleId IdType="pubmed">19095692</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A.P., Jopling C.L. Targeting viral infection by microRNA inhibition. Genome Biol. 2010;11:201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847709</ArticleId><ArticleId IdType="pubmed">20122293</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x2212;Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Fook L.W., Chow V.T. Transcriptome profiling of host&#x2013;microbe interactions by differential display RT-PCR. Methods Mol. Biol. (Clifton, NJ) 2010;630:33&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">20300989</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong W.F., Chow V.T. Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell. Microbiol. 2006;8:565&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162300</ArticleId><ArticleId IdType="pubmed">16548883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.J., Jiang T., Zhang F.J., Han J.F., Liu J., Zhao H., Li X.F., Liu R.J., Deng Y.Q., Wu X.Y., Zhu S.Y., Qin E.D., Qin C.F. Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS ONE. 2013;8:e65948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3702535</ArticleId><ArticleId IdType="pubmed">23861741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.S., Yao Y.C., Lin S.C., Lee Y.P., Wang Y.F., Wang J.R., Liu C.C., Lei H.Y., Yu C.K. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J. Virol. 2007;81:8996&#x2013;9003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.C., Yu C.K., Wang Y.F., Liu C.C., Su I.J., Lei H.Y. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 2004;85:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W.X., Yan B., Yeo H., Tan E.L., Lee J.J., Ng J.K., Chow V.T., Alonso S. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 2012;86:2121&#x2013;2131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., He Y.Q., Yi L.N., Zan H., Kung H.F., He M.L. Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J. Gastroenterol. 2011;17:4135&#x2013;4142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui Y., Timms P., Hafner L., Tan T., Tan K., Tan E. Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29. SpringerPlus. 2013;2:267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3696168</ArticleId><ArticleId IdType="pubmed">23875129</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H., Serti E., Eke O., Muchmore B., Prokunina-Olsson L., Capone S., Folgori A., Rehermann B. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology (Baltimore, MD) 2012;56:2060&#x2013;2070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581145</ArticleId><ArticleId IdType="pubmed">22706965</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterlund P., Veckman V., Siren J., Klucher K.M., Hiscott J., Matikainen S., Julkunen I. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol. 2005;79:9608&#x2013;9617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1181545</ArticleId><ArticleId IdType="pubmed">16014923</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliaccetti N.E., Eduardo R., Kleinstein S.H., Mu X.J., Bandi P., Robek M.D. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J. Biol. Chem. 2008;283:30079&#x2013;30089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2662072</ArticleId><ArticleId IdType="pubmed">18757365</ArticleId></ArticleIdList></Reference><Reference><Citation>Sainz B., Jr., Halford W.P. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 2002;76:11541&#x2013;11550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136787</ArticleId><ArticleId IdType="pubmed">12388715</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce A.T., DeSalvo J., Foster T.P., Kosinski A., Weller S.K., Halford W.P. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J. Gen. Virol. 2005;86:2421&#x2013;2432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1366490</ArticleId><ArticleId IdType="pubmed">16099899</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchizaki U., Kaneko S., Nakamoto Y., Sugiyama Y., Imagawa K., Kikuchi M., Kobayashi K. Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus. J. Med. Virol. 2003;69:188&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166598</ArticleId><ArticleId IdType="pubmed">12683406</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Onofrio C., Franzese O., Puglianiello A., Peci E., Lanzilli G., Bonmassar E. Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro. Int. J. Immunopharmacol. 1992;14:1069&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">1428362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sainz B., Jr., LaMarca H.L., Garry R.F., Morris C.A. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol. J. 2005;2:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC554982</ArticleId><ArticleId IdType="pubmed">15727684</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuse C., Rinaudo J.A., Farrar K., Wells F., Korba B.E. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Antiviral Res. 2005;65:23&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15652968</ArticleId></ArticleIdList></Reference><Reference><Citation>Larkin J., Jin L., Farmen M., Venable D., Huang Y., Tan S.L., Glass J.I. Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system. J. Interferon Cytokine Res. 2003;23:247&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">12804067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010;84:8051&#x2013;8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 2011;85:8811&#x2013;8818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 2013;87:1690&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi C., Sun Q., Wang S., Zhang Z., Li X., Cardona C.J., Jin Y., Xing Z. Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells. Virus Res. 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23685430</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., Su I.J., Wang J.R., Yeh T.M., Chen S.H., Yu C.K. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>